FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)
CUSIP: 31447P100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 34,474,972
- Total 13F shares
- 14,931,283
- Share change
- +525,358
- Total reported value
- $74,650,166
- Price per share
- $5.00
- Number of holders
- 62
- Value change
- +$2,539,947
- Number of buys
- 30
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
4,077,214
|
$24,911,778 | — | 30 Jun 2024 | |
| Sonic GP LLC |
13F
|
Company |
7%
|
2,407,357
|
$14,708,951 | — | 30 Jun 2024 | |
| DG Capital Management, LLC |
13F
|
Company |
4.7%
|
1,634,811
|
$9,988,695 | — | 30 Jun 2024 | |
| Solas Capital Management, LLC |
13F
|
Company |
3.9%
|
1,340,000
|
$8,187,400 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.4%
|
1,187,242
|
$7,254,049 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,026,654
|
$6,272,856 | — | 30 Jun 2024 | |
| HARBERT FUND ADVISORS, INC. |
13F
|
Company |
1.4%
|
466,869
|
$2,852,570 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.93%
|
321,206
|
$1,962,569 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
301,578
|
$1,842,640 | — | 30 Jun 2024 | |
| Jeffrey L. Gendell |
13F
|
Individual |
0.82%
|
283,365
|
$1,731,360 | — | 30 Jun 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.49%
|
170,000
|
$1,038,700 | — | 30 Jun 2024 | |
| Adrian Haigh |
3/4/5
|
CHIEF OPERATING OFFICER |
—
mixed-class rows
|
1,205,738
mixed-class rows
|
$832,168 | — | 16 May 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
106,399
|
$650,098 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
102,085
|
$623,739 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
69,334
|
$423,631 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
68,724
|
$419,902 | — | 30 Jun 2024 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.19%
|
67,005
|
$409,401 | — | 30 Jun 2024 | |
| CIBC WORLD MARKET INC. |
13F
|
Company |
0.17%
|
56,885
|
$348,000 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
55,452
|
$338,812 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.15%
|
53,309
|
$325,717 | — | 30 Jun 2024 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.14%
|
48,848
|
$298,462 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.14%
|
46,984
|
$287,072 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.14%
|
46,910
|
$286,620 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.1%
|
33,738
|
$206,139 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
29,110
|
$177,852 | — | 30 Jun 2024 | |
| SHERBROOKE PARK ADVISERS LLC |
13F
|
Company |
0.08%
|
28,370
|
$173,341 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
26,438
|
$161,537 | — | 30 Jun 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.08%
|
26,414
|
$161,390 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
26,006
|
$158,897 | — | 30 Jun 2024 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.07%
|
24,491
|
$149,640 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
20,134
|
$123,019 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
19,804
|
$121,002 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
17,702
|
$108,159 | — | 30 Jun 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
13,034
|
$79,638 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.04%
|
12,610
|
$77,047 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.04%
|
12,469
|
$76,186 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
12,313
|
$75,232 | — | 30 Jun 2024 | |
| Pinnacle Wealth Planning Services, Inc. |
13F
|
Company |
0.04%
|
12,289
|
$75,086 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.03%
|
11,310
|
$69,104 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
10,314
|
$63,019 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
9,762
|
$59,646 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
9,753
|
$59,591 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
9,695
|
$59,236 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
8,368
|
$51,128 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
8,086
|
$49,000 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
7,268
|
$44,407 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
6,677
|
$41,086 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,547
|
$27,782 | — | 30 Jun 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
4,526
|
$27,654 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
2,451
|
$15,061 | — | 30 Jun 2024 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q3 2024
As of 30 Sep 2024,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,931,283 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Sonic GP LLC, Solas Capital Management, LLC, DG Capital Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, HARBERT FUND ADVISORS, INC., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and GENDELL JEFFREY L.
This page lists
62
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
62
Q3 2024 holders
62
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.